{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:30:28Z","timestamp":1707525028962},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,9]]},"DOI":"10.7759\/cureus.38771","type":"journal-article","created":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T16:16:29Z","timestamp":1683648989000},"source":"Crossref","is-referenced-by-count":0,"title":["Recurrent Young Stroke With Hemianopia"],"prefix":"10.7759","author":[{"given":"Aparajit","family":"Ravikumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swathy","family":"Moorthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshmi","family":"Marappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Bhaskar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basith","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.16927","article-title":"Hyperhomocysteinemia as a risk factor for ischemic stroke: an Indian scenario","volume":"53","author":"Modi M","year":"2005","unstructured":"Modi M, Prabhakar S, Majumdar S, Khullar M, Lal V, Das CP. Hyperhomocysteinemia as a risk factor for ischemic stroke: an Indian scenario. Neurol India. 2005, 53:297-301. 10.4103\/0028-3886.16927","journal-title":"Neurol India"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2020.113541","article-title":"Hyperhomocysteinemia is an emerging comorbidity in ischemic stroke","volume":"336","author":"Poddar R","year":"2021","unstructured":"Poddar R. Hyperhomocysteinemia is an emerging comorbidity in ischemic stroke. Exp Neurol. 2021, 336:113541. 10.1016\/j.expneurol.2020.113541","journal-title":"Exp Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.22159\/ajpcr.2018.v 11i11.27595","article-title":"Serum homocysteine as a risk factor for stroke: a prospective study from a rural tertiary care centre","volume":"11","author":"Gupta N","year":"2018","unstructured":"Gupta N, Joshi S, Narang U, Bala R, Sharma R, Singla A. Serum homocysteine as a risk factor for stroke: a prospective study from a rural tertiary care centre. Asian J Pharm Clin Res. 2018, 11:174-177. 10.22159\/ajpcr.2018.v 11i11.27595","journal-title":"Asian J Pharm Clin Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00538","article-title":"Role of homocysteine in the ischemic stroke and development of ischemic tolerance","volume":"10","author":"Lehotsk\u00fd J","year":"2016","unstructured":"Lehotsk\u00fd J, Tothov\u00e1 B, Kovalsk\u00e1 M, Dobrota D, Be\u0148ov\u00e1 A, Kalensk\u00e1 D, Kapl\u00e1n P. Role of homocysteine in the ischemic stroke and development of ischemic tolerance. Front Neurosci. 2016, 10:538. 10.3389\/fnins.2016.00538","journal-title":"Front Neurosci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000019467","article-title":"The association between homocysteine and ischemic stroke subtypes in Chinese: a meta-analysis","volume":"99","author":"Zhang T","year":"2020","unstructured":"Zhang T, Jiang Y, Zhang S, et al.. The association between homocysteine and ischemic stroke subtypes in Chinese: a meta-analysis. Medicine. 2020, 99:e19467. 10.1097\/MD.0000000000019467","journal-title":"Medicine"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5489057","article-title":"The impact of homocysteine, vitamin B12, and vitamin D levels on functional outcome after first-ever ischaemic stroke","volume":"2017","author":"Marki\u0161i\u0107 M","year":"2017","unstructured":"Marki\u0161i\u0107 M, Pavlovi\u0107 AM, Pavlovi\u0107 DM. The impact of homocysteine, vitamin B12, and vitamin D levels on functional outcome after first-ever ischaemic stroke. Biomed Res Int. 2017, 2017:5489057. 10.1155\/2017\/5489057","journal-title":"Biomed Res Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1191\/1358863x02vm428ra","article-title":"Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia","volume":"7","author":"Weiss N","year":"2002","unstructured":"Weiss N, Keller C, Hoffmann U, Loscalzo J. Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia. Vasc Med. 2002, 7:227-39. 10.1191\/1358863x02vm428ra","journal-title":"Vasc Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2014.05.011","article-title":"Homocysteine level and risk of different stroke types: a meta-analysis of prospective observational studies","volume":"24","author":"He Y","year":"2014","unstructured":"He Y, Li Y, Chen Y, Feng L, Nie Z. Homocysteine level and risk of different stroke types: a meta-analysis of prospective observational studies. Nutr Metab Cardiovasc Dis. 2014, 24:1158-65. 10.1016\/j.numecd.2014.05.011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.108.529503","article-title":"Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial","volume":"40","author":"Saposnik G","year":"2009","unstructured":"Saposnik G, Ray JG, Sheridan P, McQueen M, Lonn E. Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial. Stroke. 2009, 40:1365-72. 10.1161\/STROKEAHA.108.529503","journal-title":"Stroke"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.17354\/ijss\/2015\/269","article-title":"Ocular manifestations of hyperhomocysteinemia and their response to therapeutic modalities","volume":"3","author":"Sowbhagya HN","year":"2015","unstructured":"Sowbhagya HN, Kothari M, Kumar LK, Nikhil N.. Ocular manifestations of hyperhomocysteinemia and their response to therapeutic modalities. Int J Sci Stud. 2015, 3:55-59. 10.17354\/ijss\/2015\/269","journal-title":"Int J Sci Stud"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/146335-recurrent-young-stroke-with-hemianopia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:57Z","timestamp":1707508737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/146335-recurrent-young-stroke-with-hemianopia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.38771","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,9]]}}}